Clinical Trials Logo

Filter by:
NCT ID: NCT05698446 Recruiting - Ankle Sprains Clinical Trials

Comparison of MBR + Suture Tape and Anatomic Reconstruction for CLAI in GJL Cases: A Prospective Cohort Study

Start date: November 1, 2021
Phase:
Study type: Observational

GJL is a risk factor for postoperative recurrent instability following an MBR for CLAI. BPR with suture tape augmentation and anatomic reconstruction may provide more strength and stability. However, BPR with suture tape augmentation may lead to rejection of the suture tape, while anatomic reconstruction may be associated with more trauma. In addition, the outcomes between the BPR with suture tape augmentation and anatomic reconstruction were unknown.

NCT ID: NCT05698433 Completed - Clinical trials for Blood Pressure Immeasurable

Development of a Prediction Model for Intraoperative Blood Pressure Variability

Start date: January 2, 2023
Phase:
Study type: Observational

Objective: The aim of this study was to use machine learning to predict and interpret intraoperative high blood pressure variability(IHBPV). Design: Retrospective cohort study. Setting: Beijing Tsinghua Chang Gung Hospital . Data resources: 47520 operations performed under general anesthesia in the central operating room from March 2016 to April 2022. Interventions: None. Measurements: investigators collected data on preoperative baseline information and intraoperative variables. The model was constructed with python and run using the following models: XGBoost, random forest, LGBoost, and logistic regression.

NCT ID: NCT05698407 Completed - Pregnancy Related Clinical Trials

Dexmedetomidine-Ropivacine Versus Sufentanil-Ropivacaine for Epidural Labor Analgesia

Start date: March 16, 2023
Phase: Phase 4
Study type: Interventional

Sufentanil-ropivacaine combination is commonly used for epidural labor anesthesia, but is associated with some adverse events. Dexmedetomidine is a high selective alpha2-adrenoceptor agonist. Mounting evidences show that dexmedetomidine-ropivacaine combination can also be used effectively for epidural labor analgesia. This pilot trial is designed to compare the effect of dexmedetomidine-ropivacaine combination versus sufentanil-ropivacaine combination on neonatal outcomes when used for epidural labor analgesia, and to test the feasibility of a future large randomized trial.

NCT ID: NCT05698394 Active, not recruiting - Clinical trials for Postpartum Depression

Effect of Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth

Start date: June 19, 2020
Phase: Phase 4
Study type: Interventional

Postpartum depression refers to the depression after childbirth, which is a common mental disorder in women. The pathogenesis of postpartum depression is not fully understood, and may be related to a variety of factors. Prenatal depression is an important risk factor for postpartum depression. Our recent multicenter randomized controlled trial, "Effect of Low-dose esketamine on the incidence of postpartum depression in women with prenatal depression", explored the effect of immediate postpartum intravenous infusion of low-dose esketamine on the incidence of postpartum depression in women with prenatal depression. The preliminary results showed that it reduced the incidence of postpartum depression at 42 days. Since there were no studies on the effect of intravenous esketamine infusion after delivery on long-term postpartum depression, this study is a long-term follow-up of the previous randomized trial. We aim to explore the effect of low-dose intravenous esketamine after delivery on the incidence of 2-year maternal depression after delivery in women with prenatal depressive symptoms.

NCT ID: NCT05698147 Recruiting - Clinical trials for Central Nervous System Lymphoma

Selinexor in Combination With MTX+Ritu to Treat R/R CNSL

Start date: August 3, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is a single-arm and open-label study to explore X+MTX+Ritu (ATG-010, Methotrexate, Rituximab) regimen in Relapse refractory PCNSL patients. Approximately 30 patients will be enrolled in the study. In dose escalation phase, patients with Relapse refractory PCNSL will be treated with X+MTX+Ritu regimen and escalating doses of oral ATG-010 weekly in a 3+3 design. Then a phase 2 expansion at the recommended dose level based on phase 1b trial will be conducted to evaluate the efficacy, safety and tolerability.

NCT ID: NCT05698082 Recruiting - Colorectal Cancer Clinical Trials

FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues

Start date: December 1, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

Colorectal cancer tissue sections were obtained according to the inclusion criteria. The formalin was used to immersed all cancer specimens. And tissues were cut to 5 μm thickness and placed on glass slides before staining. Endogenous peroxidase activity was inhibited and blocked by de-paraffinizing, rehydrating, and using 5% bovine serum albumin at 37ºC for 30 min. The treated sections were incubated with anti-FOS (promab 30360) at 4ºC overnight and washed three times with PBS. After that, it is required that incubation with secondary anti-peroxidation sunflower at 37ºC for 30 minutes. After washing three times again with PBS, the sections were developed in diaminobenzidine and microscopic images were made by light microscopy.

NCT ID: NCT05697926 Recruiting - Clinical trials for Head and Neck Cancer

Preclinical Research for Personalized TCR-T Therapy for Head and Neck Cancer

Start date: March 1, 2023
Phase:
Study type: Observational

This study will obtain tumor samples from patients with head and neck cancers and aims to develop personalized TCR-T therapy for head and neck cancer by determining the reactive TCR clone sequences in head and neck cancer.

NCT ID: NCT05697796 Completed - Clinical trials for Pelvic Organ Prolapse

Comparison of Post-operative Symptoms After Two Surgeries for Patients With Pelvic Organ Prolapse

Start date: November 1, 2022
Phase:
Study type: Observational

Collect and review the patients who underwent surgical treatment due to pelvic floor organ prolapse from 2020 to 2021, make statistics on their postoperative questionnaire data, and evaluate the clinical effects of different surgical methods

NCT ID: NCT05697679 Active, not recruiting - Health Behavior Clinical Trials

Effects of Physical Activiy Promotion Intervention Programs in Emerging Adulthood

Start date: June 28, 2023
Phase: N/A
Study type: Interventional

This is a prospective, double-blinded, 16-week, randomized controlled trial (RCT). Young adults aged 18-25 years are recruited in this study. Based on King's (1981) goal attainment theory, a diet-exercise program is created. The aim of this study is to investigate the impact of physiological indicators and health behaviours by conducting an exerciset programme and intensive therapy.

NCT ID: NCT05697588 Not yet recruiting - Biomarkers Clinical Trials

Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID)

Start date: February 28, 2023
Phase:
Study type: Observational

Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects more than 15% of the population over the age of 60 in China. About 15% patients with MCI could progress into dementia after two years and about one-third develop into dementia within five years, which will lead to suffering, as well as staggering economic and care burden. So, exploring the predicting biomarkers from MCI to dementia to identify and delay progression to dementia at an early stage is of great social and clinical significance. Some reports based on a single neural biomarker suggest that risk models can predict the conversion of MCI to dementia, but no widely recognized prediction models basing on multiple complex markers have been used in clinical practice. The objectives of this study are to outline the spectrum of MCI transforming into dementia through a 5-year prospective longitudinal cohort study; Secondly, screening biomarkers for MCI transmit to dementia are based on clinical symptoms, neuropsychology, neuroimaging, neuroelectrophysiology, and humoral markers tests data.